Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastrointest Pathophysiol. Dec 31, 2019; 10(5): 54-63
Published online Dec 31, 2019. doi: 10.4291/wjgp.v10.i5.54
Table 1 Patient characteristics, n (%)
CharacteristicsUC (n = 57)CD (n = 131)
GenderFemale27 (47)83 (63)
Male30 (53)48 (37)
Disease duration (yr)0-537 (65)72 (55)
6 to 109 (16)16 (12)
> 1011 (19)43 (33)
SmokingCurrent1 (2)32 (25)
Former29 (51)37 (28)
Never27 (47)62 (47)
BiomarkersLactoferrin μg/g448 (0; 8467)95 (0; 9351)
Median (min; max)CRP mg/dL0.54 (0.4; 17.3)1.15 (0.4; 21.1)
WBC (K/μL)8.2 (4.0; 29.9)7.5 (3.6; 26.4)
Montreal age (yr)A1 < 160 (0)4 (3)
A2 17-4029 (51)47 (36)
A3 > 4028 (49)80 (61)
Montreal class UCE1 proctitis4 (7)
E2 distal17 (30)
E3 extensive36 (63)
Disease activity by DAIMild (1)11 (19)
Moderate (2)27 (48)
Severe (3)19 (33)
Montreal class CDL1 ileal45 (34)
L2 colonic57 (44)
L3 ileocolonic29 (22)
L4 isolated upper0 (0)
B1 nonstricturing95 (73)
B2 stricturing24 (18)
B3 penetrating12 (9)
P perianal4 (3)
Disease activity by SES-CDInactive (0-2)9 (10)
Mild (3-6)20 (22)
Moderate (7-15)26 (28)
Severe (≥ 16)37 (40)
Table 2 Correlation of Simple Endoscopic Score for Crohn’s disease and Disease Activity Index and biomarkers
Disease severity scoreDisease markerSpearman correlation
SES-CDFL0.563b
CRP0.433b
WBC0.152
DAIFL0.330a
CRP0.410b
WBC0.099
Table 3 Spearman correlation of fecal lactoferrin with Simple Endoscopic Score for Crohn’s disease and Disease Activity Index according to timing of tests
Endoscopic scoresAnalysisFL pre colonoscopyFL post colonoscopy
SES-CDCorrelation Coefficient0.596b0.285
N5827
DAICorrelation Coefficient0.402a0.054
N3816
Table 4 Median fecal lactoferrin vs extent of colonic disease
Number of inflamed colon segmentsNumber of patientsMedian FL (µg/g)
0-1378
2-34291.5
4-521302
6-743789